Dec 31, 2022

Northrop Grumman Q4 2022 Earnings Report

Northrop Grumman reported a 16% increase in Q4 sales to $10.0 billion and a diluted EPS of $13.46, which included a per share MTM benefit of $5.96. Transaction-adjusted EPS increased 25% to $7.50. The company raised its sales outlook for 2023 and expects to deliver strong multi-year cash flow growth.

Key Takeaways

Northrop Grumman reported strong Q4 2022 results, with sales increasing by 16% to $10.0 billion. Diluted EPS was $13.46, including a $5.96 per share MTM benefit, and transaction-adjusted EPS increased 25% to $7.50. The company's performance was driven by strong demand, the timing of material receipts, and continued improvement in labor availability trends. The company is raising its sales outlook for 2023 and expects to deliver strong multi-year cash flow growth.

Q4 Sales increased 16 percent to $10.0 billion.

Q4 Diluted EPS of $13.46 including per share MTM benefit of $5.96; Q4 Transaction-Adjusted EPS increase 25 percent to $7.50.

2022 Sales of $36.6 billion; 2022 Organic Sales increase 3 percent.

Book to Bill of 1.07.

Total Revenue
$10B
Previous year: $8.64B
+16.1%
EPS
$7.5
Previous year: $6
+25.0%
Total Backlog
$78.7B
Previous year: $76B
+3.5%
Gross Profit
$1.82B
Previous year: $1.55B
+17.6%
Cash and Equivalents
$2.58B
Previous year: $3.53B
-27.0%
Free Cash Flow
$1.62B
Previous year: $709M
+128.3%
Total Assets
$43.8B
Previous year: $42.6B
+2.8%

Northrop Grumman

Northrop Grumman

Northrop Grumman Revenue by Segment

Forward Guidance

The company’s financial guidance and outlook for 2023 and beyond reflect what the company currently anticipates will be the impacts on the company from, among other factors, the global macroeconomic, health, security, and political/budget environments, including the impacts from inflationary pressures and labor and supply chain challenges

Revenue & Expenses

Visualization of income flow from segment revenue to net income